Cynergy treats vascular and pigmented lesions more effectively than conventional, single-wavelength platforms. With both a high-powered 585 nm pulsed-dye laser and a 1064 nm Nd:YAG laser, our proprietary MultiPlex technology enables the sequential emission of two wavelengths from one delivery system for optimized clinical effectiveness.
Sequential emission means that Cynergy’s sub-purpuric, pulsed-dye laser fires milliseconds before the Nd:YAG laser. This first pulse converts oxy-hemoglobin to methemoglobin, which increases the absorption coefficient for the Nd:YAG wavelength by 300–500%.2,3
Next, the Nd:YAG laser fires and is more effectively absorbed by the converted target, enabling reduced Nd:YAG fluence for enhanced patient safety. Since greater penetration depth is achieved, outcome results are also optimized.
By emitting dual wavelengths, Cynergy provides safe and effective results in less time than single-wavelength systems. For your patients, that means greater comfort and satisfaction. For you, that means greater patient throughput.
1Geronemus R J Dermatol Surg Oncol. 1993;19:303–310.
2Barton JK, et al. Optical and magnetic resonance changes in photothermally coagulating blood. Proceedings of SPIE 2002; 4609:10-19.
3Kuenstner JT, Norris KH. Spectrophotometry of human hemoglobin in the near infrared region from 1000 to 2500 nm. Near Infrared Spectrosc 1994;2:59-65.